Biotech · Private company
Renovion, Inc.
Track this companyFree. Adds Renovion, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials31 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- ARINA-1Phase 3 · Pre-Bronchiolitis Obliterans SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- ARINA-1Phase 2 · Non-cystic Fibrosis BronchiectasisClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- An Investigator-initiated Study to Evaluate Safety and Efficacy of ARINA-1 in People With a TracheostomyPHASE1 · WITHDRAWN · started May 23, 2023ClinicalTrials.gov NCT05658029 · fetched Nov 12, 2026
- Study to Evaluate ARINA-1 in the Prevention of Bronchiolitis Obliterans Progression in Participants With Bilateral Lung TransplantPHASE3 · RECRUITING · started Apr 10, 2023ClinicalTrials.gov NCT05654922 · fetched Nov 12, 2026
- Phase 2a, 28-day Investigational Use Study of ARINA-1 in Non-Cystic Fibrosis Bronchiectasis (NCFBE) With Excess Mucus and CoughPHASE2 · COMPLETED · started Oct 3, 2022ClinicalTrials.gov NCT05495243 · fetched Nov 12, 2026